|
14 Sep 2010 |
AGTC Receives Grant from Food and Drug Administration for Clinical Study of Genetic Retinal Disease
|
|
14 Sep 2010 |
Data from Clinical Trials Show Pluristem’s Placenta-Derived Cell Therapy is Safe and Improves Quality of Life and Efficacy Measurements in Patients With Critical Limb Ischemia
|
|
13 Sep 2010 |
Jennerex Presents Positive Interim Data Using JX-594 and Sorafenib to Treat Liver Cancer
|
|
13 Sep 2010 |
Geron Obtains Exclusive License for Deriving Cartilage from Human Embryonic Stem Cells from University of Edinburgh
|
|
13 Sep 2010 |
Regenerative Cellular Therapy in Chronic Kidney Disease Extends Survival; Tengion Preclinical Study Published in American Journal of Physiology Renal Physiology
|
|
13 Sep 2010 |
Diamyd Reports Promising Safety Findings from Phase I Study in Chronic Pain
|
|
13 Sep 2010 |
Marina Biotech, Inc. Announces Significant Knockdown of Gene Targets in Tumors With a microRNA Mimetic
|
|
08 Sep 2010 |
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
|
|
08 Sep 2010 |
Sylentis Receives Authorization to Commence a New Phase I/II Clinical Trial with SYL040012 for Treating Elevated Intraocular Pressure and Glaucoma
|
|
07 Sep 2010 |
Tekmira Pharmaceuticals Receives Clearance From FDA to Initiate TKM-PLK1 Phase 1 Clinical Trial
|
|
02 Sep 2010 |
New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
|
|
01 Sep 2010 |
Functional Technologies Reports Positive Results of Novel Malaria Treatment Trials
|
|
01 Sep 2010 |
Cellerant Therapeutics Awarded $153 Million Contract by Biomedical Advanced Research and Development Authority (BARDA) to Develop Treatment for Acute Radiation Syndrome (ARS)
|
|
01 Sep 2010 |
Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC
|
|
30 Aug 2010 |
Pluristem’s Placenta Derived Cells Chosen by European Commission’s Seventh Framework Program (FP7) Study for Treatment of Diastolic Heart Failure (DHF) in Type 2 Diabetic Patients
|
|
27 Aug 2010 |
Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment
|
|
26 Aug 2010 |
International Stem Cell Institute Launches Major Adipose Adult Stem Cell Therapy Program-The New Frontier of Medicine is Your Fat
|
|
25 Aug 2010 |
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
|
|
24 Aug 2010 |
Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives
|
|
24 Aug 2010 |
AVI BioPharma Announces Positive Results Against Human Pandemic H1N1 Influenza Virus in Preclinical Studies of AVI-7100
|
|
23 Aug 2010 |
Nature Medicine Publishes AVI BioPharma Preclinical Studies Demonstrating Post-Exposure Efficacy of PMOplus(TM) Oligomers Against Ebola and Marburg Viruses
|
|
23 Aug 2010 |
Alnylam and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene
|
|
19 Aug 2010 |
International Stem Cell Corporation Formalizes Stem Cell-Based Eye Care Programs into Cytovis
|
|
19 Aug 2010 |
StemCells, Inc. Reports Breakthrough Using Human Neural Stem Cells to Restore Motor Function in Chronic Spinal Cord Injury
|
|
18 Aug 2010 |
Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
|
